Chapter 34 Management of herpesvirus infections (cytomegalovirus, herpes simplex virus, and varicella-zoster virus) W. Lawrence Drew, Kim S. Erlich Cytomegalovirus General comments With the advent of highly active antiretroviral therapy…
Chapter 11 Overview of antiretroviral therapy Susa Coffey, Paul A. Volberding Introduction Antiretroviral (ARV) therapy (ART) is one of the most dramatic examples of successful drug development in the history…
Chapter 12 Development and transmission of HIV drug resistance Mark A. Wainberg, Gerasimos J. Zaharatos Introduction HIV-1 drug resistance has emerged as a major problem that limits the effectiveness of…
Chapter 40 HIV disease among substance users treatment issues R. Douglas Bruce, Frederick L. Altice, Gerald Friedland Epidemiology HIV/AIDS and illicit drug use adversely impact tens of millions of people,…
Chapter 38 Managing HIV infection in children and adolescents Elizabeth H. Doby, Andrew T. Pavia Epidemiology The epidemiology of HIV disease in children in developed countries has changed substantially. These…
Chapter 6 Acute HIV infection Anthony D. Kelleher, David A. Cooper Introduction Although HIV infection is a chronic progressive infection, it is well recognized that the initial stages of the…
Chapter 4 The immune response to HIV Clive M. Gray, Pamela Gumbi, Lycias Zembe, Mopo Radebe, Bruce Walker Introduction Most people in the world live in poverty-stricken conditions where they…
Chapter 3 Molecular biology of HIV implications for new therapies Warner C. Greene, B. Matija Peterlin, Matthew H. Stremlau Sharply curbing the expanding global HIV epidemic requires more effective approaches…
Chapter 23 Renal complications of HIV infection Jula K. Inrig, Lynda A. Szczech, Trevor E. Gerntholtz, Paul E. Klotman Introduction In the early 1980s, a unique form of kidney disease…
Chapter 16 Ocular manifestations of AIDS James P. Dunn Introduction Ocular complications include both infectious and non-infectious disorders, and can affect virtually any part of the eye. Not only is…
